(12:45 GMT) Pyxis Oncology Price Target Cut to $7.00/Share From $9.00 by Leerink Partners
Dow Jones Newswires
Pyxis Oncology Is Maintained at Outperform by Leerink Partners
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:PYXS
- Language
- English